Search hospitals > Vermont > Montpelier
Central Vermont Medical Center/National Life Cancer Treatment
Claim this profileMontpelier, Vermont 05602
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
124 reported clinical trials
16 medical researchers
Summary
Central Vermont Medical Center/National Life Cancer Treatment is a medical facility located in Montpelier, Vermont. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Central Vermont Medical Center/National Life Cancer Treatment is involved with conducting 124 clinical trials across 321 conditions. There are 16 research doctors associated with this hospital, such as Marie Wood, Alissa Thomas, Steven Ades, M.D., and Hibba Tul Rehman.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Marie WoodUCHealth University of Colorado Hospital3 years of reported clinical research
Studies Breast Cancer
Studies Tumors
9 reported clinical trials
18 drugs studied
Alissa ThomasUniversity of Vermont Medical Center2 years of reported clinical research
Studies Glioblastoma
Studies Lymphoma
8 reported clinical trials
18 drugs studied
Steven Ades, M.D.University of Vermont Medical Center4 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
10 reported clinical trials
26 drugs studied
Hibba Tul RehmanCentral Vermont Medical Center/National Life Cancer Treatment7 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
13 drugs studied
Clinical Trials running at Central Vermont Medical Center/National Life Cancer Treatment
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Squamous Cell Carcinoma
Cancer
Melanoma
Cutaneous Melanoma
Ovarian Tumors
Anal Cancer
Testicular Carcinoma
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Central Vermont Medical Center/National Life Cancer Treatment?
Central Vermont Medical Center/National Life Cancer Treatment is a medical facility located in Montpelier, Vermont. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Central Vermont Medical Center/National Life Cancer Treatment is involved with conducting 124 clinical trials across 321 conditions. There are 16 research doctors associated with this hospital, such as Marie Wood, Alissa Thomas, Steven Ades, M.D., and Hibba Tul Rehman.